2008 Agenda

7:00 – 8:30
Registration & Networking

8:30 – 9:15
Is The Pharmaceutical Industry Exposing Itself to Unacceptable Risk by Expanding Offshore Outsourcing?

Stefan Loren, Ph.D.
Vice President
Perceptive Life Sciences

9:15 – 10:15
API Sourcing: How Well Are Suppliers Responding To The Constant Change?

10:15 – 11:15
Networking and Refreshments

11:15 – 12:15
Supply Chain to Chemical Sourcing in Asia: What Are Supplier Plans To Ensure Availability of Raw Materials?

12:15 – 1:30
Networking Luncheon

1:30 – 2:30
Sourcing Synthetic Route Design and Process Optimization

Conrad Hummel, Ph.D.
Associate Director, Business Operations
Array BioPharma

Jan Oudenes, Ph.D.
President & CEO
Alphora Research

John E. Schurig, Ph.D.
Vice President, Preclinical Development
BTG International

Michael Semo
Outsourcing Consultant
Eli Lilly and Company

Lijun Sun, Ph.D.
VP, Chemistry
Synta Pharmaceuticals Corp.

Andrew Thompson
President
J-Star Research

Ken Wells, Ph.D.
Principal Scientist, High Output Synthesis, Drug Discovery
Johnson & Johnson PRD

1:30 – 2:30
Balancing Your Outsourcing Portfolio: What Goes Overseas & What Stays Home?

Peter G. Houghton, Ph.D.
Chemical Product R&D
Eli Lilly and Company

Jeff W. Jacobs, Ph.D.
Vice President, Medicinal Chemistry
Nteryx, Inc

Ving Lee, Ph.D.
CEO/CSO
Adesis

Thomas J. Niemeyer
API Strategic Sourcing and Planning
Pfizer Global Research and Development

Philip Roberts
Senior Director, Manufacturing & Outsourcing
Exelexis

Mark W. Sawicki, Ph.D.
Director, Business Development
Albany Molecular Research

Scott Zook
Director of Chemical Development
Neurocrine Biosciences

1:30 – 2:30
Why Not Look For New Molecules Abroad? External Science Collaborations

Ming Guo, Ph.D.
VP, Pharmaceutical Sciences & Manufacturing General Manager,
Ascenta (Shanghai) R&D Center
Ascenta Therapeutics, Inc.

J B Gupta, Ph.D.
Head of Collaborative Research
GVK Biosciences Pvt. Ltd.

Steven Tushup
Contract Synthesis Manager
Merck & Co., Inc.

Dean Wilson, Ph.D.
Associate Director, Chemistry
Vertex Pharmaceuticals

Christopher Yochim
Associate Director, External Relations
AstraZeneca Pharmaceuticals

1:30 – 2:00
Supplier Performance Metrics

Dean Wilson, Ph.D.
Associate Director, Chemistry
Vertex Pharmaceuticals

2:00 – 2:30
Chemistry Services Outsourcing - Early Phase Drug Discovery

Duncan Judd, Ph.D.
Outsourcing Manager, Discovery Medicinal Chemistry
GlaxoSmithKline

2:30 – 3:30
Networking and Exhibits

3:30 – 4:30
Sourcing Key Starting Materials: Excipients, Rare Reagents & Other Non-Commodity Ingredients

Kathleen Gabrielski CPM
Global Strategic Sourcing
Schering Corporation

Aída Pérez-Martí
Global Procurement -Direct Materials and Capital Procurement
Merck & Company

Jeffrey L. McGehee
Senior Manager, Strategic Sourcing & Procurement
Intervet/Schering-Plough Animal Health

Nalukui Mwisiya
Senior Scientific Sourcing Specialist
Wyeth Research

Stuart Silverman
Pharmaceutical Business Development
Capsugel, a division of Pfizer

4:30 – 5:30
Import & Export Logistics, Risk Management, Transportation & Documentation

Charles Calvert
Senior Director, Procurement
Pfizer Global Research & Development

Zhengming (Jimmy) Chen, Ph.D.
Vice President, Chemistry and PRD
DOV Pharmaceutical, Inc.

John Hollenbach
Director of Sales & Marketing
Doe & Ingalls of North Carolina

Tomas Kaplan
Senior Outsourcing Specialist
Array BioPharma

Udo Quotschalla, Ph.D.
Senior Director, Head of Global NCE Process R&D
UCB Group

3:30 – 4:30
Technical Packages for Contract Manufacturing: Quotes, Contracts, and Final Reports

Sandra Moro
Senior Manager, Business Development USA
Helsinn Chemicals SA

Conrad Hummel, Ph.D.
Associate Director, Business Operations
Array BioPharma

Rob Maddox
President
PharmaCore

Wanda Tormos
Senior Manager, Chemical Development
Gilead Sciences

James Tornos Ph.D.
Associate Director, Procurement & Outsourcing
Pfizer

Winston Wu, Ph.D.
Director, Process Chemistry
Lexicon Pharmaceuticals

Shuguang Zhu, Ph.D.
Director, Process Chemistry
Ardea Biosciences

4:30 – 5:30
Models for Drug Discovery Collaboration: FTE, BOT and Risk-Reward Sharing

Swapan Bhattacharya
Managing Director
TCG Lifesciences

M. Bhupathy, Ph.D.
Executive Director, Chemistry R & D Outsourcing
Amgen

Goutam Das, Ph.D.
Chief Operating Officer
Syngene International

John Ellingboe, Ph.D.
Assistant Vice President, Exploratory Chemistry
Wyeth Research

Narendra Mallakunta
Global Head of Business Development
GVK Biosciences Inc.

John McGill, Ph.D.
Director, External Discovery Research
Eli Lilly & Company

Sri Mosur
CEO & President
Jubilant Biosys Ltd.

3:30 – 4:30
Sourcing in Phase II to Facilitate the Commercial Activity

Kelly K. Catlin, Ph.D.
API Strategic Sourcing and Planning
Pfizer Global Research and Development

Alan Harris
Associate Director Of Business Development, Global Process R & D
AstraZeneca

David J. Houser
AD of Business Development
Asymchem Laboratories

Cuong Lu
API Strategic Sourcing & Planning, Global Supply Chain
Pfizer

Premchandran Ramiya, Ph.D.
Director, Process Development & Manufacturing
Geron Corporation

Shabbir Rangwala
VP, Clinical Research
GVK Biosciences Pvt. Ltd.

4:30 - 5:30
Biotechs Special Case: The Need for Speed

Philip Bauer, Ph.D.
Director, Process Chemistry and CMC
Gemin X Pharmaceuticals

Hui-Yin Harry Li, Ph.D.
President
Wilmington PharmaTech

Stuart Needleman
Vice President, Sales and Marketing
Aptuit

Maxwell M. Reeve, Ph.D.
Associate Director, Chemistry Manufacturing Management
Rib-X Pharmaceuticals

Silvina Garcia Rubio, Ph.D.
Director, CMC Development
Sapphire Therapeutics, Inc.

Keith Drouet, Ph.D.
Senior Director of Business Development
Cambridge Major Laboratories

Gary Visor, Ph.D.
Vice President, Chemical Operations and Pharmaceutics
Plexxikon

Roger Xie, Ph.D.
Associate Director, Chemical Operations
Sirtris Pharmaceuticals

3:30 – 4:00
M & A in Fine & Specialty Chemicals

Chris Cerimele
Managing Director & Co-Head, Global Chemicals
Lincoln International

4:00 – 4:30
Making It All Work: A Global Drug Discovery Alliance with 5 Partners

Allan R. Moorman, Ph.D.
Senior Director, Medicinal Chemistry
King Pharmaceuticals

4:30 – 5:00
Utilizing CROs in Asia to Create an Integrated Outsourcing Platform

Roger Xie, Ph.D.
Associate Director, Chemical Operations
Sirtris Pharmaceuticals

5:00 – 5:30
EU Chemical Registration & REACH Readiness

Darlene Hall
Principal Scientist, API Strategic Sourcing
Pfizer

5:30 – 6:30
Exhibitor Presentations in Ballrooms A, B & C

6:30 – 9:30
Reception & Casino Night Gaming

Tuesday, September 9, 2008 - DAY 2

7:15 – 8:30
Networking and Exhibits

8:30 – 9:30
How Will Recent Events in China Effect the Cost of Sourcing?

Robert Antonucci
Director of Supply Chain
Javelin Pharmaceuticals

Laurie Chipperfield
Director API Strategic Sourcing & Planning
Pfizer Global R&D

Hui-Yin Harry Li, Ph. D.
President
Wilmington PharmaTech

Tricia Scialla
Director, Material Operations
Chemical Development

Winston Wu, Ph.D.
Director, Process Chemistry
Lexicon Pharmaceuticals

Roger Xie, Ph.D.
Associate Director, Chemical Operations
Sirtris Pharmaceuticals

8:30 – 9:30
Chiral Synthesis: Early Project Application to Solve a Common Problem

Richard Boehner
President
Symyx Research

Donald Mammato, Ph.D.
Vice President Business Development
Novasep Synthesis

Prashant S. Savle, Ph.D.
Manager, Sourcing
Schering Plough Research Institute

William H. Tamblyn, Ph.D.
Director, Commercial Development
Johnson Matthey Catalysts

Ton Vries
CEO
Syncom BV

Gary Willingham, Ph.D.
Business Development Director
Solvias, Inc.

8:30 – 9:30
Int'l Project Team Communication: Culture, Language, Distance, Personalities

Curtis Cui
Associate Director - API Manufacturing
Inspire Pharmaceuticals

Q. Kevin Fang, Ph.D.
Director, Medicinal Chemistry
Sepracor Inc.

Peter G. Houghton, Ph.D.
Research Advisor, Chemical Product R&D
Lilly Research Laboratories

Arvind Mathur, Ph.D.
Associate Director, Discovery Chemistry
Bristol-Myers Squibb

Scott A. Miller, Ph.D.
Senior Director, Process Chemistry
Adolor Corporation

Richard Soll, Ph.D.
Vice President of Medicinal Chemistry
WuXi PharmaTech

Peter van Tilburg
General Director / President
CML Europe BV

8:30 – 9:00
Managing Discovery Chemistry Outsourcing Build A Partnership

Lijun Sun, Ph.D.
VP, Chemistry
Synta Pharmaceuticals

9:00 – 9:30
From Medicinal Chemistry to API Manufacturing, A Small Biopharma's Outsourcing Road Map

Zhengming (Jimmy) Chen, Ph.D.
Vice President, Chemistry and PRD
DOV Pharmaceutical, Inc.

9:30 – 10:30
Networking and Exhibits

10:30 – 11:30
New Process Intensification Technologies: Scaling up Hazardous Chemistries and Reducing Impurities

Sean Bradley
Director of Business Development
Regis Technologies

Mike Cruskie, Ph.D.
Vice President, Business Development
IRIX Pharmaceuticals

Deborah Minor, Ph.D.
President
Drug Discovery Alliances

Pasit Phiasivongsa, Ph.D.
Senior Manager, Chemical Development
Proteolix, Inc.

Inder Pal Singh, Ph.D.
Director Business Development
SBI Fine Chemicals, Inc

Prashant S. Savle, Ph.D.
Manager, Sourcing, Chemical & Physical Sciences
Schering-Plough Research Institute

10:30 – 11:30
Finding Good Medicinal Chemistry Partners

Christelle Renou
Outsourcing Manager
Millennium Pharmaceuticals

Normand Hebert, Ph.D.
Director, Lead and Contract Chemistry
SGX Pharmaceuticals

Mark Warne, Ph.D.
Managing Director
Exelgen, Ltd

Ashis Saha, Ph.D.
Vice President of Research
Chembiotek

Mark W. Sawicki, Ph.D.
Director, Business Development
Albany Molecular Research

C. Eric Schwartz, Ph.D.
Senior Director, Medicinal Chemistry
Resolvyx Pharmaceuticals

Dan Warner
Manager, Strategic External Resourcing
Novartis Institutes for BioMedical Research

David Zimmermann
Chief Executive Officer
Kalexsyn

10:30 – 11:30
How Much Regulatory Is Right For My Project? Also, REACH & SEMA Impact

Philip Bauer, Ph.D.
Director, Process Chemistry and CMC
Gemin X Pharmaceuticals

Darlene Hall
Principal Scientist, API Strategic Sourcing
Pfizer

Steve Kent
Business Development Manager
AstraZeneca Brixham Environmental Laboratory

Harry Kochat, Ph.D.
VP, Process Development and Manufacturing
Bionumerik Pharmaceuticals

Mike Scannell, Ph.D.
Director, Process Chemistry
SCYNEXIS

Glenn Noronha, Ph.D.
Director, Chemistry
TargeGen, Inc

Stuart Silverman
Pharmaceutical Business Development
Capsugel, a division of Pfizer

Mike Williams, Ph.D.
Director, Pharmaceutical Research & Development
Targacept, Inc.

10:30 – 11:00
The Need for More Effective Supplier Regulatory Oversight in Asia

Charles Calvert
Senior Director, Procurement
Pfizer Global Research & Development

11:00 – 11:30
Lilly's Approach to Outsourcing Process Development

Michael Semo
Outsourcing Consultant, Chemical Product R&D Outsourcing
Eli Lilly and Company

11:30 – 12:00
Advancing Agent Business Models

Carol Rose
Team Leader/Sourcing Lead
Pfizer

12:00 – 1:15
Networking Luncheon

1:15 – 2:15
Technology Transfer: PRD & IP

Edward Cheesman, Ph.D.
Director, API Development
Lantheus Medical Imaging

John Donaubauer, Ph.D.
Senior Project Leader
Abbott Laboratories

Alan Harris
Associate Director Of Business Development, Global Process R & D
AstraZeneca

Cuong Lu
API Strategic Sourcing & Planning, Global Supply Chain
Pfizer

Gale F. Matthews, Esq.
Assistant General Counsel-Patents
Wyeth

Maxwell M. Reeve, Ph.D.
Associate Director, Chemistry Manufacturing Management
Rib-X Pharmaceuticals

Thomas M. Saunders
Partner
Seyfarth Shaw LLP

2:15 – 3:30
Supplier Performance Metrics: Gauging Value on Your Relationships

Manni Kantipudi
President
GVK Biosciences Pvt. Ltd.

Stuart Needleman
Vice President, Sales and Marketing
Aptuit

Glenn Noronha, Ph.D.
Director, Chemistry
TargeGen

Mark Ralph
Manager, Medicinal Chemistry
Boehringer Ingelheim

Debra Sponholtz, Ph.D.
Director, Business Development
Chembiotek

Wanda Tormos
Senior Manager, Chemical Development
Gilead Sciences

Steven Tushup
Contract Synthesis Manager
Merck & Co

1:15 – 2:15
Selecting Commercial Suppliers: Sites Visits, Agents, Facilities, Culture, Response PAT Initiative

Jim Hamby, Ph.D.
Director of Business Development
Ash Stevens

Premchandran Ramiya, Ph.D.
Director, Process Development & Manufacturing
Geron Corporation

Carol Rose
Team Leader/Sourcing Lead API Strategic Sourcing and Planning
Pfizer

2:15 – 3:30
Manufacturing Hazardous, Difficult, and Potent APIs

Nick Bockovich, Ph.D.
Director of Pharmaceutical Development
GPC Biotech

David J. Houser
AD of Business Development
Asymchem Laboratories

Arun Kaura, Ph.D.
Investigator, Medicinal Chemistry/Oncology
GlaxoSmithKline

Scott A. Miller, Ph.D.
Senior Director, Process Chemistry
Pharmaceutical Technologies
Adolor Corporation

Thierry Van Nieuwenhove
Business Unit Manager, Pharmaceutical Fine Chemicals
Ajinomoto OmniChem N.V

Stuart Silverman
Pharmaceutical Business Development
Capsugel, a division of Pfizer

Sue Wollowitz, Ph.D.
VP, Chemistry and Manufacturing
Medivation, Inc.

1:15 – 2:15
Sourcing Finished Dose Manufacturing

Gerald Burke, Ph.D.
Director, Clinical and Commercial Manufacturing
Javelin Pharmaceuticals

Udo Quotschalla, Ph.D.
Senior Director, Head of Global NCE Process R&D
UCB

Agnes Shanley
Editorial Director
Putman Media Pharma Group

Stuart Silverman
Pharmaceutical Business Development
Capsugel, a division of Pfizer

Padraig Somers
General Manager
Helsinn Birex Pharmaceuticals Ltd

2:15 – 3:30
I Have to Scale Up to 20 Kilos in 6 Months How Am I Going to Get This Done?

Scott Chadwick, Ph.D.
Director Chemical & Pharmaceutical Operations
Anthera Pharmaceuticals, Inc.

Curtis Cui
Associate Director - API Manufacturing
Inspire Pharmaceuticals, Inc.

Deborah Minor, Ph.D.
President
Drug Discovery Alliances, Inc.

Gary Visor, Ph.D.
Vice President, Chemical Operations and Pharmaceutics
Plexxikon

Mike Williams, Ph.D.
Director, Pharmaceutical Research & Development
Targacept, Inc.

1:15 – 1:45
Procurement of Outsourced Services and Manufacture - What Works Best For You?

James Tornos Ph.D.
Associate Director, Procurement & Outsourcing
Pfizer

1:45 – 2:15
How Does REACH Affect The Pharmaceuticals Industry?

Steve Kent
Business Development Manager
AstraZeneca Brixham Environmental Laboratory

3:30
Conference Concludes